BeauSaki Bird's Nest Peptide Efficacy

Efficacy Evaluation of BeauSaki Edible Bird's Best Peptide Product

The goal of this clinical trial is to learn whether BeauSaki Edible Bird's Nest Peptide Product can improve facial skin conditions in healthy adult participants. The main questions it aims to answer are:

Can daily intake of the edible bird's nest peptide product improve facial skin hydration, elasticity, brightness, wrinkles, pores, spots, redness, and skin texture after 8 weeks?

Is the edible bird's nest peptide product well tolerated by participants during the study period?

Researchers will compare participants who take the edible bird's nest peptide capsule with participants who take a placebo capsule without edible bird's nest to see if the product improves facial skin conditions.

Participants will:

• Take one capsule daily for 8 weeks.
• Visit the study site at baseline, week 4, and week 8 for non-invasive facial skin assessments.
• Cleanse their face with water and rest under room temperature conditions for 30 minutes before each skin assessment.
• Complete a brief questionnaire about perceived skin condition and product satisfaction at baseline, week 4, and week 8.
• Have facial photographs taken for skin condition evaluation, with identifiable areas masked before disclosure.

Study Overview

• Status: Completed
• Conditions: Facial Skin Condition
• Intervention / Treatment: Dietary supplement: BeauSaki Edible Bird's Nest Peptide Product; Dietary supplement: Placebo Capsule (matched dosing schedule)

• Study Type: Interventional
• Enrollment (Actual): 40
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Taiwan
  • Taiwan
    • Tainan, Taiwan, Taiwan, 71710
      • Chia Nan University of Pharmacy ＆ Science

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Participants aged over 18 years.

Exclusion Criteria:

• Individuals who are unwilling to participate voluntarily.
• Individuals diagnosed by a physician with skin disease, liver cirrhosis, or chronic renal failure.
• Individuals with known allergies to cosmetics, drugs, or foods.
• Pregnant or breastfeeding individuals.
• Individuals taking medications for chronic diseases.
• Students taught by the principal investigator.
• Individuals unwilling to allow their study-related photographs to be disclosed. Vegetarians.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: BeauSaki Edible Bird's Nest Peptide Group; Participants in this group will take one capsule of BeauSaki Edible Bird's Nest Peptide Product daily for 8 weeks.	Dietary supplement: BeauSaki Edible Bird's Nest Peptide Product; Participants will take one capsule daily for 8 weeks.
Placebo Comparator: Placebo Group; Participants in this group will take one placebo capsule without edible bird's nest daily for 8 weeks.	Dietary supplement: Placebo Capsule (matched dosing schedule); Participants will take one placebo capsule without edible bird's nest daily for 8 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Facial Skin Analysis Parameters	VISIA Micro-Analysis Skin Image Analyzer was utilized to measure skin spots, wrinkles, texture, pores, UV spots, brown Spots, red areas, porphyrins. Units: arbitrary units. Facial skin condition will be assessed using non-invasive image-based facial skin analysis. Changes from baseline will be evaluated at week 4 and week 8.	Baseline, week 4, and week 8
Skin Moisture	Skin moisture meter (VapoMeter) was utilized to measure skin moisture. Units: g/m²h Facial skin condition will be assessed using non-invasive image-based facial skin analysis. Changes from baseline will be evaluated at week 4 and week 8.	Baseline, week 4, and week 8
Skin elasticity	Skin elastometer (Soft Plus) was utilized to measure skin elasticity. Units: arbitrary units. Facial skin condition will be assessed using non-invasive image-based facial skin analysis. Changes from baseline will be evaluated at week 4 and week 8.	Baseline, week 4, and week 8

Collaborators and Investigators

• Sponsor: Chia Nan University of Pharmacy ＆ Science

Study record dates

Study Major Dates

• Study Start (Actual): October 1, 2025
• Primary Completion (Actual): January 31, 2026
• Study Completion (Actual): March 31, 2026

Study Registration Dates

• First Submitted: July 9, 2026
• First Submitted That Met QC Criteria: July 21, 2026
• First Posted (Actual): July 23, 2026

Study Record Updates

• Last Update Posted (Actual): July 23, 2026
• Last Update Submitted That Met QC Criteria: July 21, 2026
• Last Verified: July 1, 2026

More Information

Terms related to this study

• Keywords: Wrinkles; Skin Elasticity; Transepidermal Water Loss; Skin Hydration; Skin Texture; Skin Brightness
• Other Study ID Numbers: TMSHIRB25-104-B

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No